UFP-101 acetate 是一种特异性和竞争性 NOP 受体拮抗剂 (pKi = 10.24)，其特异性是 δ、μ 和 κ 阿片受体的 3000 倍以上。

UFP-101 acetate is a selective and competitive antagonist of the NOP receptor (pKi = 10.24) with >3000-fold selectivity over δ, μ, and κ opioid receptors.

In mice submitted to the forced swimming test, UFP-101 acetate elicits a pronounced acute and dose-dependent antidepressant-like effect[2].

TP2105L

C84H142N32O23

1968.23

UFP-101 acetate(849024-68-6 free base)

(< 1 mg/ml refers to the product slightly soluble or insoluble )
Powder: -20°C for 3 years
In solvent: -80°C for 2 years